Healthcare & Life Sciences
Nereus Pharmaceuticals
United Statesnereus.us
Nereus Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Nereus Pharmaceuticals
Nereus Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Nereus Pharmaceuticals develops and markets NEREUS™, an FDA-approved prescription NK1 receptor antagonist medication used to prevent vomiting induced by motion in adults.
Explore Nereus Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.